Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center, says it will spend $1 billion over the next 4 years to develop new drugs, diagnostics, and medical devices. The investment includes a previously announced $200 million to support an immunotherapy venture with the University of Pittsburgh. In the past 2 years, UPMC Enterprises has launched five companies and invested in another, Werewolf Therapeutics. In addition to immunotherapy, it will target respiratory disease and neuroinflammation, among other illnesses.
This article has been sent to the following recipient: